Back to Top Skip to main content Skip to sub-navigation

Countering seasonal depression during the COVID-19 pandemic

Man with his head in his hands, sitting in front of a Christmas tree The holiday season can be a stressful time of year for many people. (Photo by Army Lt. Col. Keith Hickox, Joint Forces Headquarters, Pennsylvania National Guard.)

Recommended Content:

Coronavirus | Psychological Fitness | Depression | Suicide Prevention

The recent winter holidays are traditionally seen as a time of celebration and gathering with friends and family.

However, many people suffering from Seasonal Affective Disorder (SAD) may already feel that December and the New Year is a time of depression and worry. As we look to 2021 still facing travel restrictions, social distancing, the possibility of sickness from COVID-19, and now uncertainty about a vaccine – those who suffer from SAD are apt to have an even more difficult time over these winter months."

SAD, or sometimes called seasonal depression, is a subtype of a major depressive disorder. According to a National Institutes of Health, symptoms of SAD are varied, and may include feeling depressed most of the day, changes in weight or appetite, feeling sluggish or agitated, social withdrawal (feeling like “hibernating”), oversleeping, feeling hopeless, and having difficulty concentrating.

Those suffering from SAD might find themselves extra stressed and worried about family members, travel, and finances, which can contribute to feelings of depression.

If the pandemic— coupled with SAD— have you feeling out of control, you’re not alone. The pandemic has made many people feel as if they are out of control. “Recognizing our lack of control can be an important first step in coping,” explained Army Capt. (Dr.) Jacob Eliason, a psychiatry resident at Walter Reed National Military Medical Center in Bethesda, Maryland.

Eliason encourages helpful lifestyle changes to help mitigate these symptoms. These include regular exercise, a healthy diet, and getting 8 hours of rest per night.

Sometimes, however, patients who experience more disruptive mood symptoms may benefit from therapy or antidepressants. “Vitamin D supplements are [also] occasionally used to treat seasonal depression,” Eliason continued.

He also suggested sunlight therapy on sunny days, “Both are typically inexpensive and low-risk treatments but should be undertaken on an individual basis under the guidance of a [healthcare] provider.”

Another way to combat seasonal depression is partaking in fun social activities. However, due to the COVID-19 pandemic, and new social distancing guidelines throughout the country, this may be more difficult. The CDC has counseled people to maintain social distancing when possible, and to wear masks when distancing isn’t possible. Our loved ones may have medical concerns or issues we aren’t aware about, so their preference toward social distancing and mask wearing should be respected.

“In this time of year, when many of us spend time with people outside of our normal social sphere, it is important to have respectful and proactive communication with friends and family members about pandemic precautions,” said Eliason. “In fact, it is often easiest to set ground rules before social gatherings by contacting the host and letting them know what adjustments you are willing to make regarding mask wearing, food preparation, and seating arrangements.

For some people, it might mean being a little creative this season,” Eliason added.

Seasonal Depression and COVID-19 don’t have to stop us from enjoying family and friends during the pandemic. Even if we can’t be physically near, showing love and compassion to those closest to our hearts is important.  “Be willing to listen to [family and friends] if you sense they are struggling with their mental health,” said Eliason, adding that, “If low mood or anxiety continue to be disruptive, people should not hesitate to get in touch with a medical or behavioral health provider.”

You also may be interested in...

DHA-Policy Memorandum 21-004: Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

6205.01

Policy

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

20-004

Policy

Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

3020.01, Change 2

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

1020.01

Policy

Reasonable Accommodations

  • Identification #: 1020.01
  • Date: 11/2/2020
  • Type: Administrative Instructions
  • Topics: Disability Evaluation

3020.01, Change 1

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus

6025.01

Policy

Primary Care Behavioral Health (PCBH) Standards

6490.02

Policy

Behavioral Health (BH) Treatment and Outcomes Monitoring

  • Identification #: 6490.02
  • Date: 7/12/2018
  • Type: DHA Procedural Instruction
  • Topics: Substance Abuse
<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.